Alpha 2.0
Login Register
» Authors » Inna Apolikhina

Inna Apolikhina

Explore the profile of Inna Apolikhina including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 39
Followers 0
Related Specialties
Reproductive Medicine
General Medicine
Biology
Top 10 Co-Authors
Maud Jost
Steven Weyers
Janos Zatik
Celine Bouchard
Terhi Piltonen
Larisa Suturina
Jeffrey T Jensen
Andrew M Kaunitz
Gennady Sukhikh
Jean-Michel Foidart
Published In
Contraception
EPMA J
Sci Rep
PeerJ
Eur J Contracept Reprod Health Care
Affiliations
Soon will be listed here.
Recent Articles
1.
Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: data from the phase 3 clinical trial in Europe and Russia
Bitzer J, Bouchard C, Zatik J, Weyers S, Piltonen T, Suturina L, et al.
Eur J Contracept Reprod Health Care . 2024 Jun; 29(4):150-159. PMID: 38904165
Purpose: To describe the effects of estetrol (E4) 15 mgdrospirenone (DRSP) 3 mg on physical and emotional premenstrual and menstrual symptoms. Materials And Methods: We used Menstrual Distress Questionnaire (MDQ)...
2.
Hysteroscopic injections of autologous endometrial cells and platelet-rich plasma in patients with thin endometrium: a pilot randomized study
Efendieva Z, Vishnyakova P, Apolikhina I, Artemova D, Butov K, Kalinina E, et al.
Sci Rep . 2023 Jan; 13(1):945. PMID: 36653431
The aim of this study was to evaluate the efficacy of hysteroscopically controlled injections of autologous platelet-rich plasma (PRP) and autologous endometrial cells as a treatment for infertile women with...
3.
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
Chen M, Jensen J, Kaunitz A, Achilles S, Zatik J, Weyers S, et al.
Contraception . 2022 Oct; 116:44-50. PMID: 36257374
Objectives: To evaluate tolerability and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg oral contraceptive using pooled data from two, multicenter, phase 3 trials. Study Design: The two trials...
4.
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women
Kaunitz A, Achilles S, Zatik J, Weyers S, Piltonen T, Suturina L, et al.
Contraception . 2022 Aug; 116:29-36. PMID: 35921872
Objective: To evaluate the bleeding patterns of a new combined oral contraceptive containing estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg in a 24/4-day regimen. Study Design: We pooled bleeding data...
5.
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials
Jensen J, Kaunitz A, Achilles S, Zatik J, Weyers S, Piltonen T, et al.
Contraception . 2022 Aug; 116:37-43. PMID: 35921870
Objective: To evaluate overall and subgroup efficacy of an estetrol (E4) 15 mg drospirenone (DRSP) 3 mg oral contraceptive in a 24/4-day regimen. Study Design: We pooled efficacy outcomes from...
6.
Effects of platelet-rich plasma on mesenchymal stem cells isolated from rat uterus
Vishnyakova P, Artemova D, Elchaninov A, Efendieva Z, Apolikhina I, Sukhikh G, et al.
PeerJ . 2020 Dec; 8:e10415. PMID: 33335809
Background: Platelet-rich plasma (PRP), which represents a valuable source of growth factors, is increasingly being applied in regenerative medicine. Recent findings suggest the feasibility of using PRP in the treatment...
7.
Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention
Ashrafian L, Sukhikh G, Kiselev V, Paltsev M, Drukh V, Kuznetsov I, et al.
EPMA J . 2015 Dec; 6:25. PMID: 26693258
Background: The article presents the results of a clinical trial on the efficacy and safety of a novel pharmaceutical composition in the form of vaginal suppositories containing diindolylmethane in the...